opioids + alcohol = a dangerous mix
SafeRx Pharmaceuticals is a development-stage drug company pursuing FDA approval of our new proprietary ARO Platform, designed to solve a critical but previously unaddressed dimension of the U.S. opioid crisis- the combination of opioids with alcohol.
When alcohol and opioids are consumed together, they interact in a dangerous way that can severely impair the body’s ability to breathe, and according to the CDC nearly one in every four prescription opioid overdoses is related to alcohol consumption.
Yet prescribing physicians currently have no effective means of preventing their patients from making this all-too-commonly fatal mistake. We believe our Alcohol-Resistant Opioid (ARO) technology has the potential to save tens of thousands of lives and to become a new standard of care for at-risk patients.
SafeRx Pharmaceuticals has recently launched an equity crowdfunding campaign.
To learn how you can invest and support our mission to develop solutions
for the U.S. opioid crisis, CLICK HERE.
To read our white paper about the dangers of mixing alcohol and opioids, CLICK HERE.